Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antibiotics > Febuxostat for Sale > Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - large image1
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image1
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image2
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image3
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image4
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image5
Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture buy - image6

Semaglutide, CAS Number: 910463-68-2, peptide raw material, HPLC purity not less than 98 percent, bulk supply available for pharmaceutical manufacture

TDS 27 Inquiries

Unit Price:

$200-220/G FOB

Get Latest Price
CAS No.:

144060-53-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHANGHAI

Brand:

HyperChem

Packaging:

g,Kg

Price valid (until):

2026-09-23

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name

    Sermaglutide

    CAS number

    910463-68-2

    Description

    Semaglutide was originally designed as a powerful, long-lasting subcutaneous anti-diabetic drug. In 2019, oral semaglutide tablets were also approved for marketing, reducing the trauma of medication for diabetic patients and improving medication compliance and convenience.

    Molecular Formula

    C187H291N45O59

    Molecular Weight

    4113.57 g/mol

    Appearance

    White powder

    Quality Standard

    99%

    Storage Condition

    Store at -20°C.

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag

    Commercial package

    Aluminium Tin, Fiber drum

    Origin

    China

    Semaglutide Blue Trihydrate More Info

    Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk, engineered for extended half-life to enable once-weekly subcutaneous administration. It is approved for type 2 diabetes management and chronic weight management. The compound mimics endogenous GLP-1 to enhance glucose-dependent insulin secretion, suppress glucagon, and delay gastric emptying.

     


    Production and Pharmaceutical Development


    Semaglutide is synthesized via recombinant DNA technology, using yeast or mammalian cell systems, followed by chemical modification (e.g., fatty acid side chain) to prolong activity. Critical steps include peptide synthesis (SPPS or fermentation), purification, and formulation. Its design ensures stable pharmacokinetics, reducing dosing frequency compared to shorter-acting analogs.

     


    Clinical Applications and Efficacy


    Clinical trials demonstrate semaglutide’s ability to significantly reduce HbA1c (diabetes) and body weight . It also shows cardiovascular benefits, lowering MACE risk in high-risk patients. The weekly dosing regimen improves adherence versus daily GLP-1 therapies.



    Safety and Regulatory Considerations


    Semaglutide requires risk mitigation for potential adverse effects (e.g., gastrointestinal reactions, thyroid C-cell tumor risk in rodents). Patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia are contraindicated. Ongoing studies explore broader applications (e.g., NASH), while post-marketing surveillance monitors long-term safety.


    FAQ

    Q1. Can I get a free sample?

    We can send you a samll free sample, and you only need to pay for the shipping cost.


    Q2. What is the HyperChem payment term?

    T/T in advance
    LC at sight
    DP at sight

    Bank transfer

    PayPal

    Bitcoin...


    Q3. What is HyperChem shipment policy?

    Our policy is to strive for the quickest shipment time possible.

    For ready stock samples, they are usually shipped within 3 working days after payment received.
    For non-ready stock, please contact HyperChem sales team to negotiate.


    Q4. What is HyperChem shipment term?

    By Express  
    FedEx  UPS  DHL  EMS                               
    Fast: 3-7 days around, high cost, door to door service

    By Air                                        
    Suitable for more than 50kg 
    Fast: 3-7 days, hight cost, port to port, professional broker needed 

    By Sea
    Suitable for more than 500kg      
    Fast: 7-45 days, low cost, port to port, professional broker needed 


    We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.


    Q5. What HyperChem will provide after shipment?

    For sample orders: 
    After shipment is done, an timely email including:

    1. Track details (Fedex /TNT/DHL/EMS Track number)
    2. Packaging photo
    3. COA, MSDS, etc
    4. Dispatch date & Estimated arriving time
    5. Shipping invoice

    For commercial orders
    A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.



    Company Profile

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.


    Among them, our key client industrial sectors around the global are:

    Pharmaceuticals
    Nutrition Ingredients/ Dietary supplements
    Cosmetic Ingredients
    Food Ingredients
    Veterinary API
    Agriculture fertilizer
    Custom Synthesis lab supply


    HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.




    ECHEMI Editorial Reference
    Crystalline SolidFebuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues. Crystal deposition is asymptomatic, but it is revealed by bouts of
    Febuxostat is a 1,3-thiazolemonocarboxylic acid that is 4-methyl-1,3-thiazole-5-carboxylic acid which is substituted by a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally-active, potent, and selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricaemia in patients with gout. It has a role as an EC 1.17.3.2 (xanthine oxidase) inhibitor. It is an aromatic ether, a nitrile and a 1,3-thiazolemonocarboxylic acid.|Febuxostat is a xanathine oxidase (XO) inhibitor indicated in patients with gout suffering from hyperuricemia and is used in its chronic management. Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia. Febuxostat is marketed under the trade name Uloric by Takeda Pharmaceuticals America, Inc., and was approved by the FDA in February 2009.|Febuxostat is a Xanthine Oxidase Inhibitor. The mechanism of action of febuxostat is as a Xanthine Oxidase Inhibitor.|Febuxostat is a newly introduced nonpurine xanthine oxidase inhibitor used for the treatment of gout. Chronic febuxostat therapy has been associated with minor serum aminotransferase elevations, but has yet to be linked to cases of clinically apparent acute liver injury.|Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity. Upon oral administration, febuxostat selectively and noncompetitively inhibits the activity of xanthine oxidase, an enzyme that converts oxypurines, including hypoxanthine and xanthine, into uric acid. By inhibiting xanthine oxidase, uric acid production is reduced and serum uric acid levels are lowered. Febuxostat may provide protection against acute renal failure caused by the excessive release of uric acid that occurs upon massive tumor cell lysis resulting from the treatment of some malignancies.|A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.

    Certificates

    Basic Info
    Product Name:

    Febuxostat

    Other Name:

    5-Thiazolecarboxylic acid,2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid;TEI 6720;TMX 67;2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid;Febuxostat;FBX;Uloric;Feburic;Febugood;Febutaz;Zurig;2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;Adenuric

    CAS No.:

    144060-53-7

    Molecular Formula:

    C16H16N2O3S

    InChIKeys:

    InChIKey=BQSJTQLCZDPROO-UHFFFAOYSA-N

    Molecular Weight:

    316.37500

    Exact Mass:

    316.37

    UNII:

    101V0R1N2E

    NSC Number:

    758874

    DSSTox ID:

    DTXSID8048650

    NCI Thesaurus Code:

    C65629

    ATC Code:

    M04AA03|M - Musculo-skeletal system

    HScode:

    2934100090

    Categories:

    Antibiotics

    Characteristics
    PSA:

    111.45000

    XLogP3:

    3.9

    Appearance:

    Crystalline Solid

    Density:

    1.31 g/cm3

    Melting Point:

    238-239ºC

    Boiling Point:

    536.6ºC at 760 mmHg

    Flash Point:

    278.3ºC

    Refractive Index:

    1.605

    Vapor Pressure:

    2.41E-12mmHg at 25°C

    Collision Cross Section:

    180.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Certifications:

    Certification Report by Bureau Veritas

    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    27 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Febuxostat

    1.00 KG Jan 19, 2024
    India

    Febuxostat

    5.00 KG Jan 22, 2024
    Pakistan

    Febuxostat

    800.00 KG Aug 4, 2026
    India

    FEBUXOSTAT USP

    40.00 KG Oct 16, 2025
    Philippines

    Febuxostat

    1 KG Jun 2, 2026
    India

    Febuxostat

    1.00 KG May 9, 2026
    India

    Febuxostat 

    1.00 KG Apr 21, 2026
    India

    Febuxostat

    2 MT May 17, 2024
    India

    Febuxostat 

    1.00 MT Jun 16, 2026
    India

    Febuxostat

    1.00 KG Jun 4, 2026
    India

    Febuxostat

    1.00 KG May 27, 2026
    India

    Febuxostat

    100.00 KG Apr 23, 2026
    Pakistan

    Febuxostat

    300.00 KG Feb 24, 2026
    Pakistan

    Febuxostat

    50 KG Jan 12, 2026
    India

    FEBUXOSTAT 

    25.00 KG Mar 25, 2025
    India

    Febuxostat

    1.00 KG Mar 15, 2024
    India

    Febuxostat

    200.00 KG Jun 22, 2026
    Pakistan

    Febuxostat

    300.00 KG Apr 20, 2026
    Pakistan

    Febuxostat

    300.00 KG Mar 16, 2026
    India

    Febuxostat

    500.00 KG Nov 28, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.